Recent News
Enlivex receives Danish approval for knee osteoarthritis trial
Enlivex Ltd. (NASDAQ:ENLV) announced Monday it received Clinical Trial Application approval from the Danish Medicines Agency to enroll patients in Denmark for its Phase 2b trial of Allocetra, an immunotherapy for moderate-to-severe age-related symptomatic primary knee osteoarthritis.
EQS-News: Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025
Enlivex Ltd. (NASDAQ: ENLV), a quality longevity company powered by a prediction markets treasury, reported net income of $1.23 billion and diluted EPS of $25.48 for fiscal year 2025, with total treasury and treasury-related derivative assets of $2.31 billion.
Pharma firm Enlivex raises $21M for prediction market Rain token treasury
Immunotherapy company Enlivex has raised $21 million via a debt financing agreement to purchase another 3 billion tokens tied to the prediction market platform Rain.
RAIN Surges 120% After Biotech Firm Unveils $212M DAT Plans
Enlivex will use a private placement to accumulate the native token of decentralized prediction market protocol Rain.
Enlivex Raises $212M for RAIN Token Prediction Market Treasury
Enlivex raises $212M in a PIPE to launch the first RAIN prediction markets token digital asset treasury, providing investors crypto exposure
RAIN Token Explodes 100% Hourly: Did Italy’s Former PM Fuel the Surge?
The asset's market capitalization jumped above $1.7 billion.
Enlivex names former Italy PM Matteo Renzi to board, raises $212M
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) announced the appointment of former Italian Prime Minister Matteo Renzi to its board of directors, effective November 24, 2025.
Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors
Enlivex Announced today $212,000,000 private placement to initiate world's first prediction markets digital asset treasury strategy, via RAIN token accumulation
Nasdaq Biotech Firm Pivots to Crypto with $212M Investment in Prediction Market Token
Enlivex Therapeutics Invests $212 Million in Rain Token
Nasdaq penny stock plans $212M RAIN token play with ex-Italian PM onboard
A Nasdaq-listed biotech firm is raising $212 million in a late-cycle pivot into crypto, planning to buy the token of a decentralized prediction market even as other digital-asset treasuries (DATs) struggle to stay afloat.